Stay updated on Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 with no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Revision: v3.4.1 and removed the government funding operating-status notice (Revision: v3.4.0).SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide banner informs users of a lapse in government funding and potential delays in updates, noting that the NIH Clinical Center is open and directing readers to opm.gov for status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded a glossary toggle and updated metadata labels to capitalization-consistent forms (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), replacing the previous lowercase variants ('Last Update Submitted that met QC Criteria' and 'No FEAR Act data'). The revision is updated to v3.4.0.SummaryDifference0.1%

- Check36 days agoChange DetectedMinor update: Revision from v3.3.3 to v3.3.4 with no visible changes to study details, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedLocations/Contacts sections were updated with a broad new set of sites worldwide, replacing a substantial portion of the previous locations. The revision also updates the version to v3.3.3.SummaryDifference2%

Stay in the know with updates to Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.